B. Kristine Johnson's Insider Trades & SAST Disclosures
B. Kristine Johnson's most recent trade in Paragon 28 Inc was a trade of 15,906 Common Stock done . Disclosure was reported to the exchange on May 17, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern B. Kristine Johnson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Paragon 28 Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 15,906 | 47,347 | - | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 21,093 | 21,093 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 37,606 (0%) | 0% | - | Common Stock | |
| Atricure Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 7,788 | 44,409 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 17,153 | 17,153 | - | - | Restricted Stock Units | |
| Atricure Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 3,186 | 36,621 (0%) | 0% | 0 | Common Stock | |
| Paragon 28 Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 8,361 | 31,441 | - | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 7.97 per share. | 03 Jan 2023 | 431 | 20,453 (0%) | 0% | 8.0 | 3,435 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 10.19 per share. | 03 Oct 2022 | 337 | 20,022 (0%) | 0% | 10.2 | 3,434 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 12.63 per share. | 01 Jul 2022 | 272 | 19,685 (0%) | 0% | 12.6 | 3,435 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 9,269 | 19,413 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 6,179 | 6,179 | - | - | Stock Options (right to buy) | |
| Atricure Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 3,564 | 33,435 (0%) | 0% | 0 | Common Stock | |
| Paragon 28 Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,918 | 23,080 | - | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 9.96 per share. | 01 Apr 2022 | 345 | 10,144 (0%) | 0% | 10.0 | 3,436 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 11.54 per share. | 01 Jan 2022 | 595 | 9,799 (0%) | 0% | 11.5 | 6,866 | Common Stock |
| Paragon 28 Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2021 | 14,162 | 14,162 | - | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 17.92 per share. | 01 Oct 2021 | 383 | 9,204 (0%) | 0% | 17.9 | 6,863 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 20.26 per share. | 30 Jun 2021 | 257 | 8,821 (0%) | 0% | 20.3 | 5,207 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 6,006 | 6,006 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 3,003 | 8,564 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 1,749 | 29,871 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 19.57 per share. | 31 Mar 2021 | 255 | 5,561 (0%) | 0% | 19.6 | 4,990 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 5.71 per share. | 30 Sep 2020 | 876 | 4,973 (0%) | 0% | 5.7 | 5,002 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 3.55 per share. | 30 Jun 2020 | 1,406 | 4,097 (0%) | 0% | 3.5 | 4,991 | Common Stock |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 15,000 | 15,000 | - | - | Stock Options (right to buy) | |
| Atricure Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 2,452 | 28,122 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | B. Kristine Johnson | Director | Grant, award, or other acquisition of securities at price $ 3.57 per share. | 31 Mar 2020 | 1,400 | 2,691 (0%) | 0% | 3.6 | 4,998 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges